Concepedia

Mirati Therapeutics (United States)

MT

Statistics

Publications

310

Citations

107.9K

Authors

73

Location

San Diego, United States

Mirati Therapeutics (United States) is a company institution in San Diego, United States known for oncology, medicine, and molecular oncology.

HomepageROR

Top concepts

Publications

310

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Jill Hallin, Lars D. Engstrom, Lauren Hargis et al. · Cancer Discovery · 2019 · 1.3K citations · Full text

, , +17

Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation

Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2022 · 984 citations · Full text

, , +15

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS <sup>G12D</sup> Inhibitor

Xiaolun Wang, Shelley Allen, James F. Blake et al. · Journal of Medicinal Chemistry · 2021 · 708 citations · Full text

, , +14

<i>MET</i> Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent <i>MET</i> Genomic Amplification and c-Met Overexpression

Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman et al. · Journal of Clinical Oncology · 2016 · 688 citations · Full text

, , +17

Identification of the Clinical Development Candidate <b>MRTX849</b>, a Covalent KRAS<sup>G12C</sup> Inhibitor for the Treatment of Cancer

Jay B. Fell, John P. Fischer, Brian R. Baer et al. · Journal of Medicinal Chemistry · 2020 · 594 citations · Full text

, , +17

1–5 of 310

Authors

73

  1. PO
    Peter Olson

    Mirati Therapeutics (United States), United States

    285 publications · 14.7K citations

    40

    h-index

  2. RC
    Richard C. Chao

    Mirati Therapeutics (United States), United States

    186 publications · 8.5K citations

    33

    h-index

  3. JH
    Jill Hallin

    Mirati Therapeutics (United States), United States

    360 publications · 5.6K citations

    22

    h-index

  4. AI
    Anthony Ivetac

    Mirati Therapeutics (United States), United States

    68 publications · 2.7K citations

    22

    h-index

  5. II
    Igor I. Rybkin

    Mirati Therapeutics (United States), United States

    69 publications · 3.7K citations

    20

    h-index

1–5 of 73